
TY  - JOUR
TI  - Poster Sessions
JO  - Pharmacology & Toxicology
VL  - 89
IS  - S1
SN  - 0901-9928
UR  - https://doi.org/10.1111/j.0901-9928.2001.tb00002.x
DO  - doi:10.1111/j.0901-9928.2001.tb00002.x
SP  - 37
EP  - 147
PY  - 2001
ER  - 

TY  - JOUR
TI  - POSTER SESSION 2, MONDAY 25 AUGUST
JO  - European Journal of Neurology
VL  - 15
IS  - s3
SN  - 1351-5101
UR  - https://doi.org/10.1111/j.1468-1331.2008.02286.x
DO  - doi:10.1111/j.1468-1331.2008.02286.x
SP  - 222
EP  - 390
PY  - 2008
ER  - 

TY  - JOUR
C7  - e26772
TI  - SIOP ABSTRACTS
JO  - Pediatric Blood & Cancer
JA  - Pediatr Blood Cancer
VL  - 64
IS  - S3
SN  - 1545-5009
UR  - https://doi.org/10.1002/pbc.26772
DO  - doi:10.1002/pbc.26772
SP  - e26772
PY  - 2017
ER  - 

TY  - JOUR
TI  - 2013 Annual Meeting of the American Society for Bone and Mineral Research Baltimore, MD October 4–7, 2013
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 28
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.2201
DO  - doi:10.1002/jbmr.2201
SP  - S1
EP  - S1
PY  - 2013
AB  - ABSTRACT Searchable abstracts may be found at http://www.asbmr.org/education/abstracts
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Journal of Inherited Metabolic Disease
JA  - J Inherit Metab Dis
VL  - 42
IS  - S1
SN  - 0141-8955
UR  - https://doi.org/10.1002/jimd.12153
DO  - doi:10.1002/jimd.12153
SP  - 1
EP  - 479
PY  - 2019
ER  - 

TY  - JOUR
TI  - Table of Contents
JO  - The Brown University Psychopharmacology Update
JA  - Psych. Update
VL  - 20
IS  - 7
SN  - 1068-5308
UR  - https://doi.org/10.1002/pu.20095
DO  - doi:10.1002/pu.20095
SP  - 1
EP  - 8
PY  - 2009
AB  - Abstract Short-Term Quetiapine XR Monotherapy Effective for Major Depressive Disorder In Utero Valproate Exposure Linked to Poorer Cognitive Outcomes at Age 3 SIADH Caused by Multiple Atypical Antipsychotics TMS vs. Venlafaxine ER for Treatment-Resistant Depression Topiramate Treatment in Schizophrenia PDAC Conclusions Variation in COMT Associated With Duloxetine Response Quetiapine XR Patients With MDD Atomoxetine for Cognitive Impairment in Schizophrenia Chest Pain With Prazosin for PTSD New Approvals FDA and SAMHSA Launch Safety Initiative for Methadone
ER  - 

TY  - JOUR
TI  - Abstracts for the XIth World Congress of Psychiatric Genetics
JO  - American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
JA  - Am. J. Med. Genet.
VL  - 122B
IS  - 1
SN  - 1552-4841
UR  - https://doi.org/10.1002/ajmg.b.20095
DO  - doi:10.1002/ajmg.b.20095
SP  - 1
EP  - 178
PY  - 2003
ER  - 

C7  - pp. i-xxxiii
TI  - Front Matter
SN  - 9781118937006
UR  - https://doi.org/10.1002/9781118936979.fmatter
DO  - doi:10.1002/9781118936979.fmatter
SP  - i-xxxiii
PY  - 2003
AB  - Summary The prelims comprise: Half Title Title Copyright Contents List of Contributors Preface to the Fourth Edition Preface to the First Edition Historical Introduction
ER  - 

C7  - pp. 267-275
TI  - Index
SN  - 9780727918116
UR  - https://doi.org/10.1002/9780470988350.index
DO  - doi:10.1002/9780470988350.index
SP  - 267-275
PY  - 2003
ER  - 

TY  - JOUR
TI  - Abstracts of papers to be presented at the 2000 Annual Meeting Century Plaza Hotel & Tower Los Angeles, California, March 14–18, 2000*
JO  - Clinical Pharmacology & Therapeutics
JA  - Clinical Pharmacology & Therapeutics
VL  - 67
IS  - 2
SN  - 9780727918116
UR  - https://doi.org/10.1038/clpt.2000.10b
DO  - doi:10.1038/clpt.2000.10b
SP  - 89
EP  - 169
PY  - 2000
AB  - Clinical Pharmacology  doi: 10.1038/cptclpt.2000.10
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Pharmacoepidemiology and Drug Safety
JA  - Pharmacoepidemiol Drug Saf
VL  - 23
IS  - S1
SN  - 9780727918116
UR  - https://doi.org/10.1002/pds.3701
DO  - doi:10.1002/pds.3701
SP  - 1
EP  - 497
PY  - 2014
ER  - 

TY  - JOUR
TI  - Annual Symposium of the Society for the Study of Inborn Errors of Metabolism
JO  - Journal of Inherited Metabolic Disease
JA  - J Inherit Metab Dis
VL  - 33
IS  - S1
SN  - 9780727918116
UR  - https://doi.org/10.1007/s10545-010-9163-x
DO  - doi:10.1007/s10545-010-9163-x
SP  - 1
EP  - 197
PY  - 2010
ER  - 

TY  - JOUR
TI  - SSIEM 2015 Annual Symposium
JO  - Journal of Inherited Metabolic Disease
JA  - J Inherit Metab Dis
VL  - 38
IS  - S1
SN  - 9780727918116
UR  - https://doi.org/10.1007/s10545-015-9877-x
DO  - doi:10.1007/s10545-015-9877-x
SP  - 35
EP  - 378
PY  - 2015
ER  - 

TY  - JOUR
TI  - Abstract
JO  - Journal of Thrombosis and Haemostasis
JA  - Journal of Thrombosis and Haemostasis
VL  - 5
IS  - S2
SN  - 9780727918116
UR  - https://doi.org/10.1111/j.1538-7836.2007.tb00028.x
DO  - doi:10.1111/j.1538-7836.2007.tb00028.x
SP  - P-T-201
EP  - P-T-400
PY  - 2007
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Movement Disorders
JA  - Mov Disord.
VL  - 31
IS  - S1
SN  - 9780727918116
UR  - https://doi.org/10.1002/mds.26576
DO  - doi:10.1002/mds.26576
SP  - S12
EP  - S100
PY  - 2016
ER  - 

TY  - JOUR
TI  - 45th Annual Meeting of the Child Neurology Society
JO  - Annals of Neurology
JA  - Ann Neurol.
VL  - 80
IS  - s20
SN  - 9780727918116
UR  - https://doi.org/10.1002/ana.24756
DO  - doi:10.1002/ana.24756
SP  - S267
EP  - S432
PY  - 2016
ER  - 

TY  - JOUR
TI  - Proceedings of the 14th Annual Meeting of the International Society for the Study of Women's Sexual Health, Austin, USA, February 19–22, 2015
JO  - The Journal of Sexual Medicine
JA  - J Sex Med
VL  - 12
IS  - S4
SN  - 9780727918116
UR  - https://doi.org/10.1111/jsm.12922
DO  - doi:10.1111/jsm.12922
SP  - 273
EP  - 291
PY  - 2015
ER  - 

TY  - JOUR
TI  - Abstracts of papers,** Ninety-third Annual Meeting, The Peabody Hotel Orlando, Florida, March 18–20, 1992
JO  - Clinical Pharmacology & Therapeutics
JA  - Clinical Pharmacology & Therapeutics
VL  - 51
IS  - 2
SN  - 9780727918116
UR  - https://doi.org/10.1038/clpt.1992.14
DO  - doi:10.1038/clpt.1992.14
SP  - 121
EP  - 194
PY  - 1992
AB  - Clinical Pharmacology and Therapeutics (1992) 51, 121?194; doi:10.1038/clpt.1992.14
ER  - 

TY  - JOUR
TI  - Saturday, 7 July: Posters
JO  - Fundamental & Clinical Pharmacology
VL  - 15
IS  - S1
SN  - 9780727918116
UR  - https://doi.org/10.1111/j.1472-8206.2001.00012.x
DO  - doi:10.1111/j.1472-8206.2001.00012.x
SP  - 12
EP  - 51
PY  - 2001
ER  - 

TY  - JOUR
AU  - Kodama, Yasuo
AU  - Kodama, Hirofumi
AU  - Kuranari, Masae
AU  - Tsutsumi, Kimiko
AU  - Ono, Shunsuke
AU  - Fujimura, Akio
TI  - No Effect of Gender or Age on Binding Characteristics of Valproic Acid to Serum Proteins in Pediatric Patients with Epilepsy
JO  - The Journal of Clinical Pharmacology
VL  - 39
IS  - 10
SN  - 9780727918116
UR  - https://doi.org/10.1177/00912709922011728
DO  - doi:10.1177/00912709922011728
SP  - 1070
EP  - 1076
PY  - 1999
AB  - The gender- and age-related binding characteristics of valproic acid to serum proteins were determined in the pediatric population. Serum samples examined in the study were obtained from 61 pediatric patients (28 males, 33 females) with epilepsy on valproic acid monotherapy. Their ages ranged from 1to 15 years (mean age with [SD]: 7.8 [3.9] years; < 10 years, n = 41; /10 years, n = 20). The in vivo population binding parameters of valproic acid to serum proteins and theoretical minimal unbound serum fraction (fu) of valproic acid were determined in (1) all, (2) male and female subgroups, and (3) prepubescent (< 10 years) and pubescent (/10 years) subgroups. The association constant (K) was approximately 1.4 times higher in male (0.018 L/?mol) than in female (0.013 L/?mol) patients, while the total concentration of binding sites (n(Pt)) was 1.2 times greater in female (1235 ?mol/L) than in male (997 mmol/L) patients. The fu was 0.053 and 0.059 for male and female patients, respectively. The value of K was approximately 1.6 times higher in the pubescent (0.019 L/?mol) than in the prepubescent (0.012 L/?mol) patients, while the n(Pt) was 1.2 times higher in the prepubescent (1244 ?mol/L) than in the pubescent (1057 ?mol/L) patients. The fu was 0.063 for the prepubescent and 0.047 for the pubescent patients. No significant differences were observed in binding characteristics of valproic acid to serum proteins between male and female or younger and older patients. However, the differences in valproic acid binding to serum proteins appear to be relatively larger in binding affinity than in binding capacity between the two groups. Because no significant differences were observed in serum concentrations of total and unbound valproic acid, albumin, or free fatty acids between any subgroups (male and female, younger and older), the results suggest that gender or age may not be factors for the determination of the binding characteristics of valproic acid to serum proteins in pediatric patients.
ER  - 
